DK1667655T3 - Ny anvendelse, farmaceutiske præparater og en fremgangsmåde til deres fremstilling - Google Patents

Ny anvendelse, farmaceutiske præparater og en fremgangsmåde til deres fremstilling

Info

Publication number
DK1667655T3
DK1667655T3 DK04789095.9T DK04789095T DK1667655T3 DK 1667655 T3 DK1667655 T3 DK 1667655T3 DK 04789095 T DK04789095 T DK 04789095T DK 1667655 T3 DK1667655 T3 DK 1667655T3
Authority
DK
Denmark
Prior art keywords
concentrated
preparation
pharmaceutical compositions
new use
supersaturated
Prior art date
Application number
DK04789095.9T
Other languages
English (en)
Inventor
Berthold Roessler
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Application granted granted Critical
Publication of DK1667655T3 publication Critical patent/DK1667655T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04789095.9T 2003-10-01 2004-09-28 Ny anvendelse, farmaceutiske præparater og en fremgangsmåde til deres fremstilling DK1667655T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50775003P 2003-10-01 2003-10-01
PCT/US2004/031650 WO2005032515A1 (en) 2003-10-01 2004-09-28 New use, pharmaceutical preparations as well as a process for their production

Publications (1)

Publication Number Publication Date
DK1667655T3 true DK1667655T3 (da) 2011-10-24

Family

ID=34421657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04789095.9T DK1667655T3 (da) 2003-10-01 2004-09-28 Ny anvendelse, farmaceutiske præparater og en fremgangsmåde til deres fremstilling

Country Status (12)

Country Link
US (1) US8093230B2 (da)
EP (1) EP1667655B1 (da)
JP (2) JP4886517B2 (da)
AT (1) ATE516014T1 (da)
CA (1) CA2540537A1 (da)
CY (1) CY1111960T1 (da)
DK (1) DK1667655T3 (da)
ES (1) ES2369776T3 (da)
PL (1) PL1667655T3 (da)
PT (1) PT1667655E (da)
SI (1) SI1667655T1 (da)
WO (1) WO2005032515A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) * 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
ES2762880T3 (es) * 2013-05-07 2020-05-26 Auxin Surgery Sa Dispositivo para disección asistida químicamente
PL3092009T3 (pl) 2014-01-06 2020-03-31 Auxin Surgery Sa Liofilozowane kompozycje mesny
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique
EP3429555B1 (en) * 2016-03-14 2020-04-29 AuXin Surgery SA Mesna formulation and its use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
US4220660A (en) * 1977-12-14 1980-09-02 Asta-werke Aktiengesellschaft, Chemische Farik Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
US5204335A (en) 1986-10-31 1993-04-20 Asta Pharma Aktiengesellschaft Ifosfamide lyophilisate and process for its preparation
DE3862595D1 (de) 1987-03-06 1991-06-06 Asta Pharma Ag Verfahren zur herstellung von ifosfamid mit verbesserten eigenschaften.
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
DE19540132C2 (de) 1995-10-27 2003-04-03 Stada Arzneimittel Ag Ifosfamid-Lyophilisat
US6906047B2 (en) 2001-12-13 2005-06-14 Gensia Sicor Pharmaceuticals, Inc. Aqueous ifosfamide composition
US6613927B1 (en) * 2002-02-08 2003-09-02 American Pharmaceutical Partners, Inc. Sterile lyophilized ifosfamide and associated methods
KR101037313B1 (ko) 2002-09-05 2011-05-26 바라트 쎄럼스 앤드 백신스 리미티드 메스나를 함유하는 안정한 액체 옥스아자포스포린 조성물
US7199111B2 (en) 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations

Also Published As

Publication number Publication date
JP4886517B2 (ja) 2012-02-29
US8093230B2 (en) 2012-01-10
EP1667655B1 (en) 2011-07-13
ES2369776T3 (es) 2011-12-05
PL1667655T3 (pl) 2012-05-31
HK1091146A1 (en) 2007-01-12
CA2540537A1 (en) 2005-04-14
WO2005032515A1 (en) 2005-04-14
ATE516014T1 (de) 2011-07-15
CY1111960T1 (el) 2015-11-04
JP2007507506A (ja) 2007-03-29
SI1667655T1 (sl) 2011-10-28
JP2011137048A (ja) 2011-07-14
PT1667655E (pt) 2011-08-18
US20050124589A1 (en) 2005-06-09
EP1667655A1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
CY1124720T1 (el) Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων
NO20070339L (no) 1-aza-bicyklo[3 3.1]nonaner
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
MEP10408A (en) Platinum derivative pharmaceutical formulations
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
HUP0401811A2 (hu) Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
CY1111960T1 (el) Νεα φαρμακευτικα παρασκευασματα καθως επισης μεθοδος για την παρασκευη αυτων
GEP20053650B (en) Disinfectant Solution Based on Sodium Hypochlorite, and Process for Preparing It
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
HRP20041192B1 (hr) POSTUPAK PRIPRAVE PIROKSIKAM/Ăź-CIKLODEKSTRIN INKLUZIJSKIH SPOJEVA
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
EA200501301A1 (ru) Ментоловые растворы лекарственных препаратов
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.
PT1292303E (pt) Formulacao farmaceutica estavel compreendendo modificacao de torsemida ii
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
GT200400134A (es) Sistemas emulsionantes que contienen derivados de azetidina
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid
TW200609222A (en) Diazole derivatives
MX2007011826A (es) Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.